Skip to main content
logo
Radiopharm Theranostics Limited (RADX)
NASDAQ: RADX · Real-Time Price · USD
1.580
+0.060 (3.95%)
Sep 16, 2026, 9:46 AM EDT - Market open

Radiopharm Theranostics Financials Overview

Millions AUD. Fiscal year is Jul - Jun.

Revenue & Profits
Chart
Fiscal YearTTMFY 2026FY 2025FY 2024FY 2023FY 2022
Period EndingJun '26 Jun '26 Jun '25 Jun '24 Jun '23 Jun '22
Revenue
13.513.512.511.966.21-
Revenue Growth
-17.05%7.91%538.86%-68.46%--
Gross Profit
1111-18.6-19.65-13.32-7.49
Operating Income
-52.32-52.32-35.13-35.33-28.59-19.93
Net Income
-55.15-55.15-38.34-47.95-34.61-30.42
Earnings Per Share
-0.02-0.02-0.02-0.12-0.11-0.17
EPS Growth
------

Cash & Debt
Chart
Fiscal YearCurrentFY 2026FY 2025FY 2024FY 2023FY 2022
Period EndingJun '26 Jun '26 Jun '25 Jun '24 Jun '23 Jun '22
Cash & Investments
4.144.1429.1218.5811.726.98
Total Debt
------
Net Cash (Debt)
4.144.1429.1218.5811.726.98
Net Cash Growth
-88.01%-85.79%56.75%58.77%-56.64%-
Net Cash Per Share
0.000.000.010.050.040.15

Cash Flow & CapEx
Chart
Fiscal YearTTMFY 2026FY 2025FY 2024FY 2023FY 2022
Period EndingJun '26 Jun '26 Jun '25 Jun '24 Jun '23 Jun '22
Operating Cash Flow
-52.78-52.78-36.65-22.98-23.2-9.91
Capital Expenditures
-----0.05-0
Free Cash Flow
-52.78-52.78-36.65-22.98-23.25-9.91
Free Cash Flow Growth
------

Margins
Chart
Fiscal YearTTMFY 2026FY 2025FY 2024FY 2023FY 2022
Period EndingJun '26 Jun '26 Jun '25 Jun '24 Jun '23 Jun '22
Gross Margin
81.45%81.45%-148.63%--214.52%-
Operating Margin
-387.49%-387.49%-280.77%-1803.82%-460.41%-
Pretax Margin
-421.38%-421.38%-305.62%-2443.31%-556.75%-
Profit Margin
-408.44%-408.44%-306.44%-2448.23%-557.36%-
FCF Margin
-390.92%-390.92%-292.88%-1173.12%-374.36%-

Valuation
Chart
Fiscal YearCurrentFY 2026FY 2025FY 2024FY 2023FY 2022
Period EndingSep '26 Jun '26 Jun '25 Jun '24 Jun '23 Jun '22
PS Ratio
2.654.994.168.935.74-